查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439234

週边血管装置 - 全球市场考量、竞争格局、市场预测2030

Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球週边血管器械市场规模预计2023年将达到96.3亿美元，到2030年将达到151.3亿美元，2024-2030年预测期间复合年增长率为7.88%。週边血管器械的需求主要是由心血管和周边血管疾病盛行率上升、新的和先进产品的批准以及糖尿病和高血压等与生活方式相关的疾病盛行率上升所推动的。此外，老年人口的增加也可能促进週边血管器械市场的成长。

週边血管器械市场动态

根据英国心臟基金会（2022）的数据，2019 年全球约有 5.5 亿人患有心臟和循环系统疾病。根据美国心臟协会（2022）发布的数据，2020 年全球约有 2.441 亿人患有冠状动脉心臟病（缺血性心臟病）。文件进一步指出，2020年北非、中东、中亚、南亚和东欧冠心病患病率最高。

根据欧洲心臟学会 (ESC) (2023) 的数据，心血管疾病 (CVD) 每年导致欧洲 390 万人死亡，欧盟 (EU) 超过 180 万人死亡。它约占欧洲所有死亡人数的 45%，占欧盟死亡人数的 37%。根据世界卫生组织 (WHO) (2023) 的数据，全球约有 12.8 亿人患有高血压。高血压是一种严重的疾病，也是血管疾病（包括週边动脉疾病）的主要危险因子。因此，由于心血管疾病及其危险因子的盛行率不断上升，预计週边血管器械市场将在预测期内出现高速成长。

然而，频繁的产品缺陷和召回以及严格的产品审批流程可能会限制预测期内週边血管器械市场的成长。

週边血管器械市场细分分析

在周边血管器械市场的产品类型部分中，PTA球囊导管部分的药物洗脱类别预计在预测期内占据最大的市场份额。这是由于药物洗脱球囊导管所提供的优点。这些导管有效地矫正狭窄的动脉并改善血流。这种导管被认为是最安全的，併发症更少，恢復更快。

药物洗脱球囊导管将药物颗粒立即、均匀、持续地释放到血管壁中。此球囊可以安全地单独使用或与裸金属支架结合使用。这些球囊旨在保留抑制细胞分裂的潜力，有助于减少治疗后再狭窄或闭塞的再生。

因此，药物洗脱 PTA 球囊导管所提供的各种优势预计将有助于增加对该产品类型的需求，并推动整个週边血管器械市场的成长。

预计北美将主导整个週边血管器械市场。

在所有地区中，北美预计将占据週边血管器械市场的最大份额。心血管疾病盛行率的增加、获得更好的医疗基础设施以及该地区主要市场参与者的存在预计将成为预测期内推动整体市场成长的主要影响因素。

根据美国疾病管制与预防中心 (CDC) (2023) 的数据，估计美国每年约有 90 万人患有深部静脉栓塞 (DVT) 或肺栓塞 (PE)。2021年，美国心臟协会预测，到2035年，美国将有超过1.3亿成年人患有某种形式的心臟病。根据 CDC（2021）的数据，2019 年美国约有 2,870 万人患有糖尿病。糖尿病（DM）是心血管疾病的主要危险因素，已被证明不仅会增加死亡率，还会加速疾病进展。

本报告提供了全球週边血管设备市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章 週边血管器械市场报告简介

第二章週边血管器械市场摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章 週边血管器械市场关键因素分析

  • 週边血管器械市场驱动因素
    • 与生活方式相关的疾病增加
    • 周围血管疾病盛行率增加
    • 微创手术需求不断成长
    • 技术进步促进新产品开发
  • 週边血管器械市场的限制与挑战
    • 频繁的产品故障和召回
    • 严格的产品审批流程
  • 週边血管器材市场机会
    • 推出针对新兴市场的产品
    • 提高产品安全性

第五章 週边血管器械市场波特五力分析

第六章 週边血管器械市场布局

  • 按产品类型
    • PTA球囊导管
    • 血管成形术支架
    • 血小板修饰装置
    • 血流动力学流量调节装置
    • 下腔静脉过滤器
    • 其他
  • 按最终用户
    • 医院
    • 门诊手术中心
  • 按地区
    • 北美週边血管器械市场规模（2021-2030）
    • 欧洲週边血管器械市场规模（2021-2030）
    • 亚太地区週边血管器械市场规模（2021-2030）
    • 其他地区週边血管器械市场规模（2021-2030年）

第七章 週边血管器材企业及产品概况

  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Braile Biomedica
  • JOTEC GmbH
  • Edwards Life Sciences Corporation
  • LeMaitre Vascular, Inc
  • W. L. Gore & Associates, Inc
  • Abbott
  • Cardiovascular Systems Inc
  • AngioDynamics Inc
  • Control Medical Technology, LLC
  • Walk Vascular, LLC
  • Transit Scientific
  • Conic Vascular

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第十二章 免责声明与联络我们

Product Code: DIMDCL0019

Peripheral Vascular Devices Market By Product Type (Percutaneous Transluminal Angioplasty Balloon Catheters [Normal, Drug-Eluting, Cutting, and Scoring], Angioplasty Stents [Drug-Eluting, Bare-Metal, and Expandable], Plaque Modification Devices [Arthrectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], Inferior Vena cava Filters [Retrieavable And Permanent], and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of cardiovascular and peripheral vascular diseases.

The global peripheral vascular devices market was valued at USD 9.63 billion in 2023, growing at a CAGR of 7.88% during the forecast period from 2024 to 2030, to reach USD 15.13 billion by 2030. The demand for peripheral vascular devices is primarily being boosted by the rising prevalence of cardiovascular diseases and peripheral vascular diseases, the approval of new and advanced products, and the rising incidence of lifestyle disorders such as diabetes and hypertension. Furthermore, the increase in the geriatric population is also likely to contribute to the peripheral vascular devices market growth.

Peripheral Vascular Devices Market Dynamics:

According to British Heart Foundation 2022, worldwide around 550 million people were suffering from heart and circulatory diseases in 2019. As per the data published by American Heart Association 2022, about 244.1 million people were living with coronary (ischemic) heart disease in 2020 across the world. The same source further mentioned that North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates for coronary (ischemic) heart disease in 2020.

According to the European Society for Cardiology (ESC) (2023), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU. As per the data provided by the World Health Organization (WHO) 2023, about 1.28 billion people across the globe are suffering from hypertension. It is a serious medical condition and a major risk factor for vascular disorders including peripheral artery disease. Therefore, the peripheral vascular devices market is expected to register high growth in the forecast period due to the rising prevalence of cardiovascular diseases and their risk factors.

However, frequent product failures and recalls and stringent product approval processes may restrain the growth of this peripheral vascular devices market during the forecast period.

Peripheral Vascular Devices Market Segment Analysis:

Peripheral Vascular Devices by Product Type (PTA Balloon Catheters [Normal, Drug-Eluting, Cutting, and Scoring], Angioplasty Stents [Drug-Eluting, Bare-Metal, and Expandable], Plaque Modification Devices [Arthrectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], Inferior Venacava Filters [Retrievable and Permanent], and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the peripheral vascular devices market, the drug-eluting category under the PTA balloon catheters segment is expected to account for the largest market share during the forecast period. This can be attributed to the advantages offered by drug-eluting balloon catheters. These catheters lead to an effective reduction in the narrowing of arteries, resulting in improved blood flow. It is considered as one of the safest approaches with minimal procedural complications, and faster recovery periods.

Drug-eluting balloon catheters offer immediate, homogenous, and sustained release of drug particles to the vessel wall. They can be used alone or in combination with a bare metal stent without many issues. These balloons are devised in such a way that they hold the potential to inhibit cell division which in turn helps in limiting the amount of restenosis, or blockage re-growth after treatment.

Therefore, various advantages offered by the drug-eluting PTA balloon catheters, are predicted to contribute to the increasing demand for this product type, thereby driving the growth of the overall peripheral vascular devices market.

North America is expected to dominate the overall Peripheral Vascular Devices Market:

Among all the regions, North America is expected to amass the largest share of the peripheral vascular devices market. The growing prevalence of cardiovascular diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

According to the Centers for Disease Control and Prevention (CDC) 2023 data, it has been estimated that approximately 900,000 people are affected by deep vein thrombosis (DVT) or pulmonary embolism (PE) each year in the United States. The American Heart Association in 2021 projected that by 2035, more than 130 million US adults will have some sort of heart disease. As per CDC 2021, around 28.7 million people in the US had diabetes in 2019. It has been established that diabetes mellitus (DM) is a major risk factor for cardiovascular diseases, which leads to increased mortality and as well as hastens the disease progression course.

Furthermore, in October 2020, Boston Scientific Corporation received FDA clearance for Ranger(TM) Paclitaxel-Coated PTA Balloon Catheter which is a drug-coated balloon. It is deployed in the re-opening of the blocked or narrowed arteries in the thigh and knee due to peripheral artery disease (PAD).

Considering the presence of a large patient pool in the US coupled with new product launches, the market for peripheral vascular devices looks promising in the United States, and subsequently in North America.

Key Peripheral Vascular Devices Companies Market:

Some of the key peripheral vascular devices companies operating in the market include Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., AngioDynamics Inc, Control Medical Technology, LLC, Walk Vascular, LLC, Transit Scientific, Conic Vascular, and others.

Recent Developmental Activities in Peripheral Vascular Devices Market:

In June 2021, AngioDynamics Inc received 510k clearance from the US Food and Drug Administration for their AlphaVac Mechanical Thrombectomy System. The device is an off-circuit, multi-purpose mechanical aspiration thrombectomy system which is deployed in the non-surgical removal of emboli or thrombi from the vasculature.

In May 2021, Transit Scientific received the CE Mark clearance in the European Union for the XO Score® Scoring Sheath Platform. This device facilitates the dilation of stenotic material in the peripheral vasculature including infrapopliteal, popliteal, and native or synthetic arteriovenous dialysis fistulae.

In January 2021, Cardiovascular Systems, Inc. received the CE Mark for Diamondback 360® Coronary Orbital Atherectomy System. It combines differential sanding and pulsatile forces to treat all calcium modalities, including eccentric (irregular), nodular, and concentric (ring-shaped).

Key Takeaways from the Peripheral Vascular Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the peripheral vascular devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Peripheral Vascular Devices Market.

Various opportunities are available for the other competitor in the Peripheral Vascular Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current peripheral vascular devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for peripheral vascular devices market growth in the coming future?

Target audience who can be benefited from This Peripheral Vascular Devices Market Report Study

Peripheral Vascular Devices products providers

Research organizations and consulting companies

Peripheral Vascular Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in peripheral vascular devices

Various End-users who want to know more about the Peripheral Vascular Devices market and the latest technological developments in the Peripheral Vascular Devices market.

Frequently Asked Questions for Peripheral Vascular Devices Market:

What is a Peripheral Vascular Device?

A peripheral vascular device is a medical device that helps in the treatment of blockages and narrowing of the arteries specifically in the peripheral vasculature.

What is the market for Global Peripheral Vascular Devices?

Global Peripheral Vascular Devices Market was valued at USD 9.63 billion in 2023, growing at a CAGR of 7.88% during the forecast period from 2024 to 2030, to reach USD 15.13 billion by 2030.

What are the drivers for Global Peripheral Vascular Devices Market?

The major drivers of the peripheral vascular devices market are the increasing prevalence of cardiovascular diseases as well as peripheral vascular diseases, the growing elderly population, and technological innovation in product development.

What are the key players operating in Global Peripheral Vascular Devices Market?

Some of the prominent market players operating in the peripheral vascular devices market includes Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., AngioDynamics Inc, Control Medical Technology, LLC, Walk Vascular, LLC, Transit Scientific, Conic Vascular and others.

What region has the highest share in the Peripheral Vascular Devices market?

North America is expected to account for the largest revenue share in the overall peripheral vascular devices market during the forecast period, 2024 to 2030. This high growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, conducive healthcare system and policies in the region, especially in the US.

Table of Contents

1. Peripheral Vascular Devices Market Report Introduction

2. Peripheral Vascular Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Peripheral Vascular Devices Market Key Factors Analysis

  • 4.1. Peripheral Vascular Devices Market Drivers
    • 4.1.1. Rising Incidence of Lifestyle Disorders
    • 4.1.2. Increasing Prevalence of Peripheral Vascular Diseases
    • 4.1.3. Growing Demand for Minimally-Invasive Procedures
    • 4.1.4. Technological Advancements Leading to New Product Development
  • 4.2. Peripheral Vascular Devices Market Restraints and Challenges
    • 4.2.1. Frequent Product Failures and Recalls
    • 4.2.2. Stringent Product Approval Process
  • 4.3. Peripheral Vascular Devices Market Opportunities
    • 4.3.1. Targeting Emerging Markets for Product Launches
    • 4.3.2. Product Improvement in Terms of Safety

5. Peripheral Vascular Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Peripheral Vascular Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. PTA Balloon Catheters
      • 6.1.1.1. Normal
      • 6.1.1.2. Drug-Eluting
      • 6.1.1.3. Cutting
      • 6.1.1.4. Scoring
    • 6.1.2. Angioplasty Stents
      • 6.1.2.1. Drug-Eluting
      • 6.1.2.2. Bare-Metal
      • 6.1.2.3. Expandable
    • 6.1.3. Plaque Modification Devices
      • 6.1.3.1. Atherectomy Devices
      • 6.1.3.2. Thrombectomy Devices
    • 6.1.4. Hemodynamic Flow Alteration Devices
      • 6.1.4.1. Embolic Protection Devices
      • 6.1.4.2. Chronic Total Occlusion Devices
    • 6.1.5. Inferior Venacava Filters
      • 6.1.5.1. Retrievable
      • 6.1.5.2. Permanent
    • 6.1.6. Others
  • 6.2. By End-User
    • 6.2.1. Hospitals
    • 6.2.2. Ambulatory Surgical Centers
    • 6.2.3. Others
  • 6.3. By Geography
    • 6.3.1. North America Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.1.1. United States Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Peripheral Vascular Devices Market Size in USD million (2021-2030)
    • 6.3.2. Europe Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.1. France Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Peripheral Vascular Devices Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.1. China Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.3. India Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia-Pacific Peripheral Vascular Devices Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW) Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.4.1. Middle East Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Peripheral Vascular Devices Market Size in USD million (2021-2030)

7. Peripheral Vascular Devices Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Boston Scientific Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. B. Braun Melsungen AG
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Braile Biomedica
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. JOTEC GmbH
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Edwards Life Sciences Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. LeMaitre Vascular, Inc
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. W. L. Gore & Associates, Inc
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Abbott
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Cardiovascular Systems Inc
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. AngioDynamics Inc
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Control Medical Technology, LLC
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Walk Vascular, LLC
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Transit Scientific
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Conic Vascular
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Peripheral Vascular Devices Market in Global (2021-2030)
  • Table 3: Peripheral Vascular Devices Market in Global by Product Type (2021-2030)
  • Table 4: Peripheral Vascular Devices Market in Global by End-User (2021-2030)
  • Table 5: Peripheral Vascular Devices Market in Global by Geography (2021-2030)
  • Table 7: Peripheral Vascular Devices Market in North America (2021-2030)
  • Table 11: Peripheral Vascular Devices Market in the US (2021-2030)
  • Table 12: Peripheral Vascular Devices Market in Canada (2021-2030)
  • Table 13: Peripheral Vascular Devices Market in Mexico (2021-2030)
  • Table 14: Peripheral Vascular Devices Market in Europe (2021-2030)
  • Table 18: Peripheral Vascular Devices Market in France (2021-2030)
  • Table 19: Peripheral Vascular Devices Market in Germany (2021-2030)
  • Table 20: Peripheral Vascular Devices Market in the United Kingdom (2021-2030)
  • Table 21: Peripheral Vascular Devices Market in Italy (2021-2030)
  • Table 22: Peripheral Vascular Devices Market in Spain (2021-2030)
  • Table 24: Peripheral Vascular Devices Market in Rest of Europe (2021-2030)
  • Table 25: Peripheral Vascular Devices Market in APAC (2021-2030)
  • Table 29: Peripheral Vascular Devices Market in China (2021-2030)
  • Table 30: Peripheral Vascular Devices Market in Japan (2021-2030)
  • Table 31: Peripheral Vascular Devices Market in India (2021-2030)
  • Table 32: Peripheral Vascular Devices Market in Australia (2021-2030)
  • Table 33: Peripheral Vascular Devices Market in South Korea (2021-2030)
  • Table 34: Peripheral Vascular Devices Market in Rest of APAC (2021-2030)
  • Table 35: Peripheral Vascular Devices Market in the Rest of the World (2021-2030)
  • Table 39: Peripheral Vascular Devices Market in the Middle East (2021-2030)
  • Table 40: Peripheral Vascular Devices Market in Africa (2021-2030)
  • Table 41: Peripheral Vascular Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Peripheral Vascular Devices Market in Global (2021-2030)
  • Figure 3: Peripheral Vascular Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Peripheral Vascular Devices Market in Global by End-User (2021-2030)
  • Figure 5: Peripheral Vascular Devices Market in Global by Geography (2021-2030)
  • Figure 6: Peripheral Vascular Devices Market in North America (2021-2030)
  • Figure 7: Peripheral Vascular Devices Market in the US (2021-2030)
  • Figure 8: Peripheral Vascular Devices Market in Canada (2021-2030)
  • Figure 9: Peripheral Vascular Devices Market in Mexico (2021-2030)
  • Figure 10: Peripheral Vascular Devices Market in Europe (2021-2030)
  • Figure 11: Peripheral Vascular Devices Market in France (2021-2030)
  • Figure 12: Peripheral Vascular Devices Market in Germany (2021-2030)
  • Figure 13: Peripheral Vascular Devices Market in the United Kingdom (2021-2030)
  • Figure 14: Peripheral Vascular Devices Market in Italy (2021-2030)
  • Figure 15: Peripheral Vascular Devices Market in Spain (2021-2030)
  • Figure 16: Peripheral Vascular Devices Market in Rest of Europe (2021-2030)
  • Figure 17: Peripheral Vascular Devices Market in APAC (2021-2030)
  • Figure 18: Peripheral Vascular Devices Market in China (2021-2030)
  • Figure 19: Peripheral Vascular Devices Market in Japan (2021-2030)
  • Figure 20: Peripheral Vascular Devices Market in India (2021-2030)
  • Figure 21: Peripheral Vascular Devices Market in Australia (2021-2030)
  • Figure 22: Peripheral Vascular Devices Market in South Korea (2021-2030)
  • Figure 23: Peripheral Vascular Devices Market in Rest of APAC (2021-2030)
  • Figure 24: Peripheral Vascular Devices Market in the Rest of the World (2021-2030)
  • Figure 25: Peripheral Vascular Devices Market in the Middle East (2021-2030)
  • Figure 26: Peripheral Vascular Devices Market in Africa (2021-2030)
  • Figure 27: Peripheral Vascular Devices Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis